Scoring system related inflammation and nutrition to predict prognoss of patients with hepatocellular carcinoma undergoing liver transplantation

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: Hepatocellular carcinoma is a common malignant tumor in the liver. The prognostic predictive roles of inflammatory and nutrition-related markers in liver transplant patients with liver cancer remain unclear. Methods : 239 patients with hepatocellular carcinoma undergoing liver transplantation were randomly divided into a training set and a validation at a 7:3 ratio. The optimal cut-off values for each indicator were determined using Maximally Selected Rank Statistics; a risk score (RS) was constructed using LASSO-Cox regression, and the optimal cut-off value of the RS was determined in the training set. A nomogram was further established and its predictive efficacy was evaluated. Results: The risk score (RS) was ultimately included in three variables: FAR, GAR, and GPAR, with a cutoff value of 0.47. Patients in the high RS group had significantly poorer overall survival than those in the low RS group (P < 0.05), and this result was confirmed in the validation set and the subgroups meeting the Milan/Hangzhou criteria. Multivariate Cox analysis showed that high RS (HR = 2.174) and microvascular invasion (HR = 2.633) were independent risk factors. Based on these two factors, a nomogram was constructed, and the 1/3/5-year AUCs were 0.764/0.762/0.747 (training set) and 0.722/0.716/0.722 (validation set), and both calibration curves and decision curve analysis showed good consistency and clinical net benefit. Conclusion: The preoperative risk score integrating FAR, GAR and GPAR can independently predict the overall survival of HCC patients after liver transplantation, providing a simple and practical new tool for clinical rapid prognosis assessment, individualized follow-up and adjuvant treatment strategy formulation.

Article activity feed